期刊文献+

膀胱癌合并前列腺增生同期行经尿道等离子电切术 被引量:2

Transurethral resection of bladder cancer with benign prostatic hyperplasia
下载PDF
导出
摘要 目的:非肌层浸润性膀胱癌合并前列腺增生同期行经尿道等离子电切术治疗的临床效果。方法:所选研究对象为医院收治的非肌层浸润性膀胱癌合并前列腺增生患者,年限为2015年1月-2017年1月,符合标准的有21例。所有患者均实施等离子膀胱肿瘤切除术联合经尿道等离子电切术同期治疗。患者及家属均知情同意,比较治疗前后患者的前列腺症状改善情况。结果:治疗后,患者最大尿流率、残余尿量、国际前列腺症状评分均优于治疗前,差异有统计学意义(P<0.05);患者均顺利完成手术,均痊愈出院,术中均未出现相关并发症;术后随访12个月,所有患者均未出现严重并发症,且无复发。结论:在非肌层浸润性膀胱癌合并前列腺增生患者治疗中,同期行经尿道等离子电切术治疗的效果理想,值得进行深入研究和推广。 Objective:The clinical effect of non - muscular infiltrating bladder cancer combined with prostatic hyperplasia of prostate hyperplasia.Methods:The selected study subjects were the patients with non-muscular infiltrative bladder cancer combined with prostatic hyperplasia, and the duration of the study was January 2015 to January 2017. There were 21 cases in accordance with the criteria. All patients underwent plasma cystectomy combined with transurethral plasma electrotomy. Patients and their families informed consent to compare the improvement of prostate symptoms before and after treatment.Results:After treatment,the maximum urinary flow rate, residual urine volume and international prostate symptom score were superior to the treatment before treatment, and the results were statistically significant (P〈 0.05). All the patients in this group had successfully completed the operation, and all of them recovered from the hospital. No complications occurred during the operation. After 12 months of follow-up, none of the patients had serious complications and no recurrence occurred.Conclusion:In the treatment of non-muscular infiltrating bladder cancer with prostate hyperplasia, the effect of the treatment of the urethral plasma electrotomy in the same period is ideal, which deserves further study and promotion.
作者 袁吴靓 陈俊
出处 《安徽卫生职业技术学院学报》 2017年第6期41-42,共2页 Journal of Anhui Health Vocational & Technical College
关键词 非肌层浸润性膀胱癌 前列腺增生 经尿道等离子电切术 Non-muscular layer infiltrating bladder cancer Prostate hyperplasia Transurethral plasma electrotomy
  • 相关文献

参考文献9

二级参考文献80

  • 1陶逸然,金讯波,王慕文,赵勇,于潇.吉西他滨联合顺铂新辅助化疗治疗肌层浸润性膀胱癌的临床疗效观察[J].泌尿外科杂志(电子版),2014,6(2):23-28. 被引量:12
  • 2黄健.膀胱癌诊断治疗指南[M]//那彦群,叶章群,孙颖浩等.中国泌尿外科疾病诊断治疗指南(2014版),北京:人民卫生出版社,2014:36-37.
  • 3Eduardo Solsona,Inmaculada Iborra,Argimiro Collado,José Rubio-Briones,Juan Casanova,Ana Calatrava.Feasibility of Radical Transurethral Resection as Monotherapy for Selected Patients With Muscle Invasive Bladder Cancer[J].The Journal of Urology.2010(2)
  • 4Nargund VH, Tanabalan CK, Kabir MN. Management of non - muscle - invasive ( Superficial ) bladder tumou [ J ]. Semin Oncol, 2012,39 (5) :559 - 572.
  • 5Heney NM, Ahmed S, Flanagan MJ, et al. Superficial bladder canc- er:progression and recurrence [ J 1. J Urol, 1983,130 : 1083 - 1086.
  • 6Tochigi T, Sakurada Y, Aoki H, et al. The intravesical recurrence after 3 - day consecutive intravesical instillation of pirarubicine hydrochlorice (THP)following transurethtal resectiong of baldder tumor(TURBT) for non - muscle - invasive baldder cancer[ J ]. Ni- bon Hinyokika Gakkai Zasshi,2012,103(4) :610 -616.
  • 7Mens MC, Metts JC, Milito SJ, et al. Bladder cancer: a review of diagnosis and management [ J ]. J Natl Med Assoc, 2000,92 ( 6 ) : 285 - 294.
  • 8Hautmann RE, de Petriconi RC, Pfiffer C, et al. Radical cystectomy for urothelial carcinoma of the bladder without neoadjuvant or adjuvant therapylong-term results in 1100 patients [ J]. Eur Uro1,2012,61 ( 5 ) : 1039-1047. DOI : 10. 1016/j. eururo. 2012.02. 028.
  • 9Nishiyama H, Habuchi T, Watanabe J, et al. Clinicaloutcome of alarge-scale multi-institutional retrospective study for locally advanced bladder cancer:a survey including 1131 patients treated during 1990-2000 in Japan[ J]. Eur Urol,2004,45(2) :176-181.
  • 10Stein JP,Lieskovsky G, Cote R,et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1054 patients [ J ]. J Clin Onco1,2001,19 ( 3 ) :666-675.

共引文献162

同被引文献16

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部